VanEck Pharmaceutical ETF
PPH
PPH
44 hedge funds and large institutions have $57.7M invested in VanEck Pharmaceutical ETF in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 14 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
69.87% less ownership
Funds ownership: 102.62% → 32.75% (-70%)
72% less capital invested
Capital invested by funds: $206M → $57.7M (-$148M)
Holders
44
Holding in Top 10
–
Calls
$2.34M
Puts
$1.65M
Top Buyers
| 1 | +$3.98M | |
| 2 | +$581K | |
| 3 | +$81K | |
| 4 |
MIH
Meitav Investment House
Bene-Beraq,
Israel
|
+$74.3K |
| 5 |
WI
Wintrust Investments
Chicago,
Illinois
|
+$65.3K |
Top Sellers
| 1 | -$72.7M | |
| 2 | -$49.2M | |
| 3 | -$4.45M | |
| 4 |
Goldman Sachs
New York
|
-$4.32M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$893K |